| Castration-Resistant Prostate Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 115show all (up to 200) |
|---|
| → investigated in trials for | Enzalutamidesmall_molecule 88 trials (35 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 88 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 37 trials (13 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall_molecule 30 trials (14 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall_molecule 29 trials (12 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abiraterone Acetatesmall_molecule 29 trials (11 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall_molecule 21 trials (12 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall_molecule 21 trials (10 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 20 trials (8 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 19 trials (12 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Vipivotide Tetraxetanother 17 trials (12 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 14 trials (11 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apalutamidesmall molecule 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Castration-Resistant Prostate Carcinoma | 10 | Observed | clinicaltrials | graph → |